The motor phenotype of Parkinson's disease in relation to age at onset.
about
Diagnosis and treatment of dystoniaParkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and DiagnosisResearch Priorities in Limb and Task-Specific DystoniasAutomatic Classification on Multi-Modal MRI Data for Diagnosis of the Postural Instability and Gait Difficulty Subtype of Parkinson's Disease.Assessment of patients with isolated or combined dystonia: an update on dystonia syndromes.A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need.The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients.Asian perspectives on the recognition and management of levodopa 'wearing-off' in Parkinson's disease.Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia.Non-motor symptoms in a Flanders-Belgian population of 215 Parkinson's disease patients as assessed by the Non-Motor Symptoms QuestionnaireEpidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United StatesSensory aspects of movement disorders.A Personalized Approach to Parkinson's Disease Patients Based on Founder Mutation AnalysisParkinson's Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery CohortGenetic risk and age in Parkinson's disease: Continuum not stratum.Profile of idiopathic parkinson's disease in Moroccan patients.Pains in Parkinson disease--many syndromes under one umbrella.Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesisParkinson's disease: chameleons and mimics.Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.How close are we to individualized medicine for Parkinson's disease?Age at onset and Parkinson disease phenotype.Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease.SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.Pramipexole and its extended release formulation for Parkinson's disease.Altered Functional Connectivity Density in Subtypes of Parkinson's Disease.Part 2: Introduction to the Pharmacotherapy of Parkinson's Disease, With a Focus on the Use of Dopaminergic Agents.Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies.Nigral iron deposition occurs across motor phenotypes of Parkinson's disease.Statistical Models of Parkinson's Disease Progression: Predictive Validity in a 3-Year Follow-up.Rest tremor in idiopathic adult-onset dystonia.
P2860
Q26830473-AA28D2C1-02F7-4051-BD6E-1534D0583DCAQ28384572-635160AA-CE23-4F88-8372-AA0074F6D729Q30572682-BC83A258-0081-44B7-B040-DA280EC94ABAQ31095916-7E6CD877-16AA-44A4-AADA-E0D52BF371A6Q34438061-4AA413CE-169B-439A-B714-5F64D88B1EFFQ34611889-38C6EAD7-363E-4A27-A590-731BCF6EDAD5Q34925276-7826A255-822C-4429-8892-D2B48BA42ADAQ35781883-A7463115-F90B-484F-8026-B0B925621340Q36400471-B6131073-45EA-4766-805A-A4BD2887FE4DQ36576449-DCAB790F-4EA4-498B-89BC-C8106F0A21C0Q36582373-D49419DA-B8D6-4F8A-BD7C-0F34DF0A2538Q36595746-A2225E74-3F7F-4FC6-A0FD-25ECCF36B521Q36885946-1155A6DE-4878-42A2-8C5E-3205C47A3D47Q37044196-4DA0AD6B-B22A-4EF6-A091-B6030A26F5E9Q37566664-C0BF8F19-2398-4070-AC2A-835748A96E8FQ37624971-85AD7D29-97D6-40AB-BF99-9E3A8444FC51Q38003055-CB2C39D2-EF12-465D-98D8-87CE5C09A81EQ38128462-FC09873A-F812-4C2A-B7AB-0541691A6686Q38254117-32A18295-2360-4D4D-9551-61B627B68575Q38811387-EB48FFF8-9694-4850-B349-1C54F54987D3Q38814888-CFDD29E1-900D-4D62-BAF4-0823FC7F2BB3Q38909662-E022AFCF-990C-485B-BB5A-C4BADF49EA25Q39119095-63068B84-6066-4EF5-B4FD-8193B8B97B78Q40047619-DA50D631-F0CC-4DA1-B163-7255F82BAC28Q40860918-71A215AA-7B7F-42E0-9559-9FBE91E0682BQ41021587-013961E0-C325-45A8-9B9E-073EF7FEA22AQ42097113-8ED08934-FDF2-4EA8-9AB2-E5ACDE70C1D6Q43248920-1431C15D-142B-4213-BCF0-F20F73AF74D4Q47648607-8F849524-0B5C-46C1-ADE9-A473611BDFB2Q48685391-28CD6B83-A219-4C0E-81E7-BC582B70648DQ50241406-76C8A47C-3235-47E8-B047-4AD563FFB080Q50243192-B5B5D987-EC3E-47ED-91E2-4D9BAA153AB1
P2860
The motor phenotype of Parkinson's disease in relation to age at onset.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
The motor phenotype of Parkinson's disease in relation to age at onset.
@en
The motor phenotype of Parkinson's disease in relation to age at onset.
@nl
type
label
The motor phenotype of Parkinson's disease in relation to age at onset.
@en
The motor phenotype of Parkinson's disease in relation to age at onset.
@nl
prefLabel
The motor phenotype of Parkinson's disease in relation to age at onset.
@en
The motor phenotype of Parkinson's disease in relation to age at onset.
@nl
P2093
P50
P356
P1433
P1476
The motor phenotype of Parkinson's disease in relation to age at onset.
@en
P2093
Anne Jones
B S Dwarakanath Sastry
Debbie Davies
Elizabeth Morgan
Huw R Morris
Louise Ebenezer
Maralyn Moran
Mirdhu M Wickremaratchi
Neil P Robertson
Rachel Salmon
P304
P356
10.1002/MDS.23469
P407
P577
2011-01-12T00:00:00Z